Advisornet Financial’s Acadia Pharmaceuticals ACAD Stock Holding History

Advisornet Financial’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12	Closed	-$199	–	2228
2025 Q1	$199	Hold	12	–	–	﹤0.01%	2075
2024 Q4	$220	Hold	12	–	–	﹤0.01%	1874
2024 Q3	$185	Buy	+12	New	+$200	﹤0.01%	2126
2024 Q1	–	Sell	-740	Closed	-$23.2K	–	2034
2023 Q4	$23.2K	Hold	740	–	–	﹤0.01%	1037
2023 Q3	$15.4K	Hold	740	–	–	﹤0.01%	1118
2023 Q2	$17.7K	Hold	740	–	–	﹤0.01%	1135
2023 Q1	$13.9K	Hold	740	–	–	﹤0.01%	1201
2022 Q4	$11.8K	Hold	740	–	–	﹤0.01%	1247
2022 Q3	$12K	Hold	740	–	–	﹤0.01%	1275
2022 Q2	$10K	Hold	740	–	–	﹤0.01%	1326
2022 Q1	$18K	Hold	740	–	–	﹤0.01%	1271
2021 Q4	$17K	Hold	740	–	–	﹤0.01%	1324
2021 Q3	$12K	Hold	740	–	–	﹤0.01%	1394
2021 Q2	$18K	Hold	740	–	–	﹤0.01%	1252
2021 Q1	$19K	Sell	740 -110	-13%	-$4.84K	﹤0.01%	1201
2020 Q4	$45K	Buy	850 +110	+15%	+$5.46K	﹤0.01%	895
2020 Q3	$31K	Hold	740	–	–	﹤0.01%	968
2020 Q2	$36K	Hold	740	–	–	﹤0.01%	941
2020 Q1	$31K	Hold	740	–	–	﹤0.01%	942
2019 Q4	$32K	Sell	740 -24	-3%	-$1.04K	﹤0.01%	1031
2019 Q3	$27K	Buy	+764	New	+$23.2K	﹤0.01%	1100

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Advisornet Financial's ACAD Position: Q2 2025 in Review

Advisornet Financial sold out of Acadia Pharmaceuticals (ACAD) in Q2 2025, closing a stake of 12 shares — an estimated $199 sold.

Advisornet Financial first reported a position in ACAD in Q3 2019 and held it in 21 quarters. The position peaked at $45K in Q4 2020. 311 funds tracked by Wall St. Rank hold ACAD as of Q2 2025.

Advisornet Financial reported no remaining Acadia Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Advisornet Financial sold 12 Acadia Pharmaceuticals shares in Q2 2025, an estimated $199.
Advisornet Financial first reported a position in Acadia Pharmaceuticals in Q3 2019 and held it in 21 quarters.
Advisornet Financial's Acadia Pharmaceuticals position peaked at $45K in Q4 2020.
311 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2025.

Based on Advisornet Financial's 13F filing for Q2 2025, filed 14 Jul 2025.